IE
LEGN icon

Israel Englander’s Legend Biotech LEGN Stock Holding History

Israel Englander’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,100
Closed -$947K – 6326
2023
Q3 		$947K Buy
+14,100
New +$979K ﹤0.01% 4225
2022
Q4 		– Sell
-30,000
Closed -$1.22M – 6821
2022
Q3 		$1.22M Buy
+30,000
New +$1.41M ﹤0.01% 4165
2022
Q2 		– Sell
-50,000
Closed -$1.82M – 7251
2022
Q1 		$1.82M Buy
+50,000
New +$1.98M ﹤0.01% 3981
2021
Q2 		– Sell
-18,700
Closed -$543K – 6830
2021
Q1 		$543K Buy
+18,700
New +$510K ﹤0.01% 4758

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Israel Englander's LEGN Position: Q2 2026 in Review

Israel Englander sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 284,911 shares — an estimated $5.15M sold.

Israel Englander first reported a position in LEGN in Q2 2020 and held it in 23 quarters. The position peaked at $73.5M in Q2 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Israel Englander reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 284,911 Legend Biotech shares in Q2 2026, an estimated $5.15M.
  • Israel Englander first reported a position in Legend Biotech in Q2 2020 and held it in 23 quarters.
  • Israel Englander's Legend Biotech position peaked at $73.5M in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.